Decreased Heart Rate Variability in COVID-19
Abstract Purpose Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which primarily infects the lower airways and binds to angiotensin-converting enzyme 2 (ACE2) on alveolar epithelial cells. ACE2 is widely expressed not only in the lungs b...
Main Authors: | Chengfen Yin, Jianguo Li, Zhiyong Wang, Yongle Zhi, Lei Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2022-12-01
|
Series: | Intensive Care Research |
Subjects: | |
Online Access: | https://doi.org/10.1007/s44231-022-00024-1 |
Similar Items
-
Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19
by: Naci Şenkal, et al.
Published: (2020-07-01) -
Chronic Obstructive Pulmonary Disease and COVID-19: A Double Trouble
by: Jyoti Bajpai, et al.
Published: (2021-11-01) -
Renin-angiotensin system in the pathogenesis of COVID-19 and possible drug targets
by: Sujay Halkur Shankar, et al.
Published: (2021-01-01) -
Associations Between the Use of Renin–Angiotensin System Inhibitors and the Risks of Severe COVID-19 and Mortality in COVID-19 Patients With Hypertension: A Meta-Analysis of Observational Studies
by: Xiao-Ce Dai, et al.
Published: (2021-04-01) -
Effects of the COVID‐19 pandemic on heart failure hospitalizations in Japan: interrupted time series analysis
by: Tetsuji Morishita, et al.
Published: (2022-02-01)